Diabetes Mellitus, Non-Insulin-Dependent
Item
male or female patients with type 2 diabetes mellitus
boolean
C0011860 (UMLS CUI [1])
Hemoglobin A1c measurement
Item
6.5% ≤ hba1c < 9.0%
boolean
C0474680 (UMLS CUI [1])
Sulfonylurea Discontinued Duration | Biguanide Discontinued Duration
Item
stopped treatment of sulfonylurea and biguanide for more than 8 weeks
boolean
C0038766 (UMLS CUI [1,1])
C1444662 (UMLS CUI [1,2])
C0449238 (UMLS CUI [1,3])
C0005382 (UMLS CUI [2,1])
C1444662 (UMLS CUI [2,2])
C0449238 (UMLS CUI [2,3])
Antidiabetics Discontinued Duration
Item
stopped treatment of other anti-diabetic agents for more than 12 weeks
boolean
C0935929 (UMLS CUI [1,1])
C1444662 (UMLS CUI [1,2])
C0449238 (UMLS CUI [1,3])
Body mass index
Item
16 kg/m2 ≤ body mass index < 30 kg/m2
boolean
C1305855 (UMLS CUI [1])
Glucose measurement, fasting
Item
fasting glucose ≥ 200 mg/dl
boolean
C0202045 (UMLS CUI [1])
Patient need for Insulin regime
Item
required insulin therapy
boolean
C0686904 (UMLS CUI [1,1])
C0557978 (UMLS CUI [1,2])
Neuropathy | Retinal Disease | Kidney Disease
Item
patients with neuropathy, retinopathy or renopathy
boolean
C0442874 (UMLS CUI [1])
C0035309 (UMLS CUI [2])
C0022658 (UMLS CUI [3])
Medical contraindication Mitiglinide | Medical contraindication Sitagliptin
Item
contraindicated for mitiglinide or sitagliptin
boolean
C1301624 (UMLS CUI [1,1])
C0906166 (UMLS CUI [1,2])
C1301624 (UMLS CUI [2,1])
C1565750 (UMLS CUI [2,2])